Overview

Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas

Status:
Terminated
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This study is for patients who have been treated before and either the treatment did not work or the lymphoma has come back.
Phase:
Phase 2
Details
Lead Sponsor:
University of Southern California
Treatments:
Doxorubicin
Liposomal doxorubicin
Rituximab